Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: PD-1 inhibitors combined with paclitaxel and cisplatin in first-line treatment of esophageal squamous cell carcinoma (ESCC): a network meta-analysis

Fig. 3

Forest plots of all individual regimens compared with PD1 + TP. HRs and 95% credible intervals are given. A PFS of all individual regimens compared with PD1 + TP; B OSs of all individual regimens compared with PD1 + TP; C ORRs of all individual regimens compared with PD1 + TP; D ≥ 3TRAEs of all individual regimens compared with PD1 + TP

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us